[1] 李建芳. 基层医院血浆凝固酶阴性葡萄球菌感染现状和耐药性分析[J]. 实用预防医学, 2007, 14(2):361-362. [2] Usha MG, Shwetha DC, Vishwanath G. Speciation of coagulase negative Staphylococcal isolates from clinically significant specimens and their antibiogram[J]. Indian J Pathol Microbiol, 2013, 56(3):258-260. [3] Schuetz P, Mueller B, Trampuz A. Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci[J]. Infection, 2007, 35(5):352-355. [4] Pacifico L, Osborn JF, Natale F, et al. Procalcitonin in pediatrics[J]. Adv Clin Chem, 2013, 59:203-263. [5] Russell JA. Management of sepsis[J]. N Engl J Med, 2006, 355(16):1699-1713. [6] Hall KK, Lyman JA. Updated review of blood culture contamination[J]. Clin Microbiol Rev, 2006, 19(4):788-802. [7] Haimi-Cohen Y, Shafinoori S, Tucci V, et al. Use of incubation time to detection in BACTEC 9240 to distinguish coagulase-negative staphylococcal contamination from infection in pediatric blood cultures[J]. Pediatr Infect Dis J, 2003, 22(11):968-974. [8] Shomali W, Hachem R, Chaftari AM, et al. Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia?[J]. Diagn Microbiol Infect Dis, 2013, 76(2):158-161.